Virax Biolabs Group Limited (VRAX)

Nasdaq: VRAX · In Vitro & In Vivo Diagnostic Substances · Lanarkshire, GB · filing with the SEC since 2021

Grade3.3

◀ Past 3.0● Present 3.0▶ Future 3.9

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in March.

The Form 20-F filed Jul 6, 2026 for the period ended Mar 31, 2026 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.

Income statement, by fiscal year, newest first
Fiscal year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Report filed	Jul 6, 2026	Jul 2, 2025	Aug 20, 2024	Jun 14, 2023	Aug 12, 2022	·
Revenue	12,423	6,331	156,419	8,561	0	123,820
For lenders
Net interest income	-61,772	-58,179^r	-26,878	-15,468	-15,438	-28,643
Cost of revenue	4,733	59,398	105,829	9,926	·	133,254
Gross profit	7,690	-53,067	50,590	-1,365	·	-9,434
Research and development	3,738,358	2,031,335^r	1,614,636^r	2,179,341^r	433,743	120,221
Sales and marketing	·	·	·	26,616	13,818	57,203
General and administrative	2,669,062	3,992,400^r	4,571,279^r	3,552,055^r	1,299,936^r	457,680
Total operating expenses	6,407,420	6,023,735^r	6,576,270^r	5,731,396	1,733,679	635,104
Operating income	-6,399,730	-6,076,802^r	-6,525,680^r	-5,732,761	-1,733,679	-644,538
Income before income taxes	-5,932,424	-6,203,893	-6,739,120	-5,457,763	-1,749,870	-672,915
Income tax expense	-900,240	-136,661	0	·	·	·
Net income	-5,032,184	-6,067,232	-6,739,120	-5,457,763	-1,749,870	-672,915
Net income to non-controlling interests	-8,434	-5,985	-5,583	-269	-41,043	-21,931
Net income to shareholders	-5,023,750	-6,061,247	-6,733,537	-5,457,494	-1,708,827	-650,984
Earnings per share, basic	-12.64	-40.62^r	-83.90^r	-128.25^rb	-44.75^rb	·
Earnings per share, diluted	-12.64	-40.62^r	-83.90^r	-128.25^rb	-44.75^rb	·
Weighted average shares, basic	397,590	149,214^r	80,257^r	42,519^rb	38,253^rb	6,326^b
Weighted average shares, diluted	397,590	149,214^r	80,257^r	42,519^rb	38,253^rb	1,581,443

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it soldifrs-full:RevenueFromContractsWithCustomers

Net interest income interest earned less interest paidifrs-full:InterestRevenueExpense

Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales

Gross profit revenue less the cost of what it soldifrs-full:GrossProfit

Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersifrs-full:SellingExpense

General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherifrs-full:OperatingExpense

Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities

Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax

Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations

Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss

Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests

Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent

Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare

Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare

Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares

Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares

SI Assistanton VRAX · research, not advice